内分泌T广义用于对抗
dromlakhani2026-10-24查看 793复制 216
该指南不建议将睾酮普遍用于不孕症、除HSDD以外的性功能障碍、认知、心血管、代谢、骨骼健康或一般健康等适应症，因为获益证据不足且缺乏长期安全性数据。当临床医生考虑为绝经后女性除确诊的性欲减退障碍以外的任何适应症开具睾酮时，应考虑此建议。
📘如何使用这个技能
- 1复制技能内容·点击上方「Copy SKILL.md」复制全部内容，或 Download 下载到本地
- 2打开你的 AI 客户端·支持 Claude Code、Trae、Cursor、ChatGPT、DeepSeek、Kimi 等任意 AI 助手
- 3粘贴为系统提示/知识文件·Claude Code：放入 .claude/skills/ 目录；普通对话：作为首条消息发送并说「请严格按这份技能文档执行」
- 4直接提出你的需求·AI 会按技能定义的工作流、格式和约束来处理，无需再解释背景
💡 提示：技能生效后，每次对话只需一句需求，AI 会按 SKILL.md 的流程执行。
SKILL.md2875 chars
--- name: endo-t-generalized-use-against description: The guideline recommends against generalized testosterone use for indications such as infertility, sexual dysfunction other than HSDD, cognitive, cardiovascular, metabolic, bone health, or general well-being due to insufficient evidence of benefit and lacking long-term safety data. Consider this recommendation when a clinician contemplates prescribing testosterone for any indication other than confirmed hypoactive sexual desire disorder in postmenopausal women. --- # Recommend against generalized testosterone use for non-HSDD indications ## STEP 1 — Gather Information Collect the specific indication for testosterone request, confirm menopausal status, and determine whether a diagnosis of hypoactive sexual desire disorder (HSDD) has been established. **Action:** Proceed to step 2. ## STEP 2 — Rule In / Rule Out Determine if the indication is HSDD in a postmenopausal woman. **Action:** If yes, testosterone may be considered per recommendation 4.1 (outside this skill); if no, proceed to step 3. ## STEP 3 — Classify or Stratify Classify the non-HSDD indication into one of the following categories: infertility, sexual dysfunction other than HSDD, cognitive dysfunction, cardiovascular dysfunction, metabolic dysfunction, bone health, or general well-being. **Action:** Proceed to step 4. ## STEP 4 — Decide Recommend against prescribing testosterone for the given indication due to lack of clear indications and insufficient long-term safety data. **Action:** Do not initiate testosterone therapy; discuss alternative approaches. ## Clinical Guardrails / Mimics / Pitfalls Do not prescribe testosterone for non-HSDD indications based on low androgen levels alone; avoid unapproved or compounded formulations lacking safety data; do not use testosterone to treat fatigue, mood, or cognitive symptoms without an HSDD diagnosis; monitor for signs of androgen excess (acne, hirsutism, voice changes) if testosterone is used off-label; recognize that government‑approved dose‑appropriate preparations for women are not widely available. ## Concrete Clinical Example A 58‑year‑old postmenopausal woman presents with low energy and decreased libido but does not meet criteria for HSDD. She requests testosterone for “vitality.” The clinician gathers information, confirms the indication is not HSDD, classifies it as general well‑being, and recommends against testosterone, discussing lifestyle modifications and evaluating for other causes of fatigue. **Source:** Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline, Endocrine Society, American Congress of Obstetricians and Gynecologists (ACOG), American Society for Reproductive Medicine (ASRM), European Society of Endocrinology (ESE), International Menopause Society (IMS), 2014, DOI:10.1210/jc.2014-2260